Twenty-Four-Hour Antihypertensive Efficacy of Felodipine 10 mg Extended-Release: The Italian Inter-University Study

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 2, 1996, Pages 255-261

  Pannarale, Giuseppe ^a,e   Puddu, Paolo Emilio ^a   Monti, Francesco ^a   Irace, Luigi ^b   Bentivoglio, Maurizio ^c   Collauto, Fabio ^a   Barsotti, Antonio ^d   Corea, Luigi ^c   Trevi, Gianpaolo ^d   Campa, Pietro Paolo ^a   Jacono, Aldo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e NONE   (Italy)

Author keywords

Ambulatory blood pressure monitoring; Dihydropyridines; Felodipine extended release; Hypertension

Indexed keywords

FELODIPINE; PLACEBO;

ADULT; AGED; AMBULATORY MONITORING; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; ITALY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE BLOOD VESSEL;

ADULT; AGED; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FELODIPINE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0030060478     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199602000-00012     Document Type: Article

References (25)

1. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee: 1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993;11:905-18.
2. Bostrum S-L, Lyjung B, Maroh S, Forsen S, Thulin E. Interaction of the antihypertensive drug felodipine with calmodulin. Nature 1981;292:777-8.
3. Pickering TG, Pieper C. Methods of analysis of ambulatory blood pressure data. In: Pickering TG, ed. Ambulatory monitoring and blood pressure variability. London: Science Press, 1991:10.
4. Pickering TG. Clinical aspects of ambulatory monitoring and determinants of normal ambulatory blood pressure. In: Pickering TG, ed. Ambulatory monitoring and blood pressure variability. London: Science Press, 1991:6.
5. Mancia G, Salvetti A. Il rapporto valle/picco nella valutazione di un farmaco antipertensivo. G Ital Cardiol 1994;24:1043-8.
6. Rose M, McMahon FG. Some problems with antihypertensive drug studies in the context of the new guidelines. Am J Hypertens 1990;3:151-5.
7. Zanchetti A, on behalf of the Italian Nifedipine GITS Study Group. Trough:peak ratio of the blood pressure response to dihydropyridine calcium antagonists. J Hypertens 1994;12(suppl 8):S97-106.
8. Myers MG. Trough-to-peak ratio and 24-hour blood pressure control. Am J Hypertens 1995;8:214-9.
9. Pocock SJ. Clinical trials: A practical approach. London: John Wiley & Sons, 1984.
10. SOLO statistical system. SOLO power analysis. Los Angeles: BMDP Statistical Software, 1992.
11. Dixon WJ, chief ed. BMDP statistical software manual: to accompany the 7.0 software release. Berkeley: University of California Press, 1992.
12. Evans SJ, Mills P, Dawson J. The end of p value?. Br Heart J 1988;60:177-80.
13. Mutti E, Trazzi S, Omboni S, Parati G, Mancia G. Effect of placebo on 24-h noninvasive ambulatory blood pressure. J Hypertens 1991;9:361-4.
14. Pannarale G, Serafini GL, Spadaro O, Arciero M. Effetto placebo e pressione arteriosa. Minerva Cardioangiol 1994;42:173-6.
15. Elliott HL, Meredith PA. Methodological considerations in calculation of the trough:peak ratio. J Hypertens 1994;12(suppl 8):S3-7.
16. Fariello R, Boni E, Corda L, et al. Extended release felodipine in essential hypertension. Variations in blood pressure during whole-day continuous ambulatory recording. Am J Hypertens 1991;4:27-33.
17. Weber MA, Goldberg AI, Faison EP, et al. Extended-release felodipine in patients with mild to moderate hypertension. Clin Pharmacol Ther 1994;55:346-52.
18. Lederle RM, Wetzchewald D, Lederle E. Antihypertensive efficacy and trough to peak ratios of felodipine ER 5 and 10 mg in patients with primary hypertension. A double-blind, crossover study using ambulatory blood pressure measurement. Drug Invest 1994;8:369-76.
19. Porcellati C, Verdecchia P, Gatteschi C, et al. Ambulatory blood pressure monitoring during sustained treatment with conventional and extended-release felodipine in mild-to-moderate hypertension. Eur J Clin Pharmacol 1989;37:555-7.
20. Bainbridge AD, Herlihy O, Meredith PA, Elliot HL. A comparative assessment of amlodipine and felodipine ER: pharmacokinetic and pharmacodynamic indices. Eur J Clin Pharmacol 1993;45:425-30.
21. Pedersen O, Christensen NJ, Raemsch KD. Comparison of acute effects of nifedipine in normotensive and hypertensive man. J Cardiovasc Pharmacol 1980;2:357-66.
22. Pannarale G, Puddu PE, Villatico Campbell S, Collauto F, Stazi F, Reale A. Effects of slow-release verapamil and nitrendipine on office and 24-hour ambulatory blood pressure in hypertensive patients. J Cardiovasc Pharmacol 1992;19(suppl 2):S53-6.
23. Gould BA, Hornung RS, Mann S, Balasubramanian V, Raftery EB. Slow channel inhibitors verapamil and nifedipine in the management of hypertension. J Cardiovasc Pharmacol 1982;4(suppl 4):S269-73.
24. Yusuf S. Calcium antagonists in coronary artery disease and hypertension: time for reevaluation? [Editorial]. Circulation 1995;92:1079-82.
25. Lipicky RJ. Trough:peak ratio: the rationale behind the United States Food and Drug Administration recommendations. J Hypertens 1994;12(suppl 8):S17-9.